Quest Diagnostics (DGX) – FDA
-
Quest Diagnostics (DGX) and Diadem SpA Enter Exclusive U.S. Licensing Agreement for AlzoSure Predict Alzheimer's Disease Prognostic Technology
-
Quest Diagnostics (DGX) granted Breakthrough Device Designation from FDA for AAV test
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DGX Stock Lookup